Health Condition 1: L209- Atopic dermatitis, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Children aged between 6 months and 5 years with a clinical diagnosis of dermatitis considered suitable for topical therapy were eligible for inclusion. Only patients with limited disease involvement, defined as target lesions affecting not more than 10 percent of the total body surface area, were enrolled. Lesions were required to be located on the trunk or extremities. Written informed consent was obtained from the parent or legal guardian prior to inclusion in the study.
Exclusion criteria
Exclusion criteria: Children with a known history of hypersensitivity to Aloe vera, probiotics, or any of the formulation excipients were excluded. Patients presenting with infected, ulcerated, or actively weeping skin lesions were not considered for enrolment. Those with severe chronic dermatological conditions requiring systemic therapy, as well as children receiving systemic corticosteroids or other immunosuppressive medications, were also excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in pruritus score Improvement in skin condition score (SCORAD)Timepoint: baseline and after 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in sleep quality, Caregiver satisfaction, Treatment adherenceTimepoint: Baseline and after 4 weeks | — |
Countries
India
Contacts
Saveetha medical college hospital